iTeos Therapeutics, Inc. (ITOS) Misses Q4 EPS by 2c

iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q4 EPS of ($0.85), $0.02 worse than the analyst estimate of ($0.83).

For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• L3Harris CEO steps down amid conduct review, shares drop
• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance